Trebicka, Jonel 1976-
Jonel Trebicka
VIAF ID: 20790291 ( Personal )
Permalink: http://viaf.org/viaf/20790291
Preferred Forms
- 100 0 _ ‡a Jonel Trebicka
- 100 1 _ ‡a Trebicka, Jonel ‡d 1976-
- 100 1 _ ‡a Trebicka, Jonel ‡d 1976-
4xx's: Alternate Name Forms (4)
5xx's: Related Names (1)
- 551 _ _ ‡a Korca (Albanien) ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
Works
Title | Sources |
---|---|
Autophagy-related activation of hepatic stellate cells reduces cellular miR-29a by promoting its vesicular secretion | |
Behandlungsstrategien der portalen Hypertonie bei der Leberzirrhose durch die Modulation des intrahepatischen Widerstands | |
Combination of phosphodiesterase‐5‐inhibitors and beta blockers improves experimental portal hypertension and erectile dysfunction | |
Comparison of short-course antibiotic therapy of 6 or less days with a longer treatment in patients with cholangitis after liver transplantation | |
Differential lipidomics, metabolomics and immunological analysis of alcoholic and non-alcoholic steatohepatitis in mice | |
Effekte von Udenafil und Propranolol auf die portale Hypertension und erektile Dysfunktion in der experimentellen Leberzirrhose | |
Einfluss von Erythrozytentransfusionen auf die Mortalität von intensivpflichtigen Patienten mit Leberzirrhose | |
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope Consortium | |
Four-and-a-half LIM-domain protein 2 (FHL2) induces neuropeptide Y (NPY) inmacrophages in visceral adipose tissue and promotes diet-induced obesity | |
Hämodynamische und renale Wirkung der Angiotensin-II-Typ1-Rezeptorblockade bei Ratten mit sekundärer biliärer Zirrhose | |
Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects | |
microbiota in cirrhosis and its role in hepatic decompensation | |
Molecular surveillance of carbapenem-resistant gram-negative bacteria in liver transplant candidates | |
A new treatment for chronic hepatitis B and D offers novel insights into obesity and hepatic steatosis | |
Phosphodiesterases in the liver as potential therapeutic targets of cirrhotic portal hypertension | |
Portal hypertension in cirrhosis Pathophysiological mechanisms and therapy | |
Preoperative TIPS prevents the development of postoperative acute-on-chronic liver failure in patients with high CLIF-C AD score | |
Pulmonary impairment independently determines mortality in critically ill patients with acute-on-chronic liver failure | |
Quantitative Phase Imaging Using Digital Holographic Microscopy to Assess the Degree of Intestinal Inflammation in Patients with Ulcerative Colitis | |
Response to: Aspirin for patients after TIPS. An old dog with new tricks? | |
Rolle der Glyoxalase-I im hepatozellulären Karzinom | |
Smaller-diameter covered transjugular intrahepatic portosystemic shunt stents are associated with increased survival | |
Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018) | |
Use and outcome of TIPS in hospitalized patients in Germany: a nationwide study (2007–2018) | |
Zur Bedeutung von mechanischer Beatmung und Lungenversagen als Risikofaktoren im akut-auf-chronischen Leberversagen |